X-Linked Protoporphyria (XLP)
Metabolic·MeSH: Protoporphyria, Erythropoietic, X-Linked Dominant
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| bitopertin | Disc Medicine, Inc. (IRON) |
Frequently asked questions
How many drugs are in development for X-Linked Protoporphyria (XLP)?
BioSniper tracks 1 drug in development for X-Linked Protoporphyria (XLP) across 1 company.
How many clinical trials target X-Linked Protoporphyria (XLP)?
There are 2 clinical trials targeting X-Linked Protoporphyria (XLP) tracked by BioSniper.
Deep-dive into X-Linked Protoporphyria (XLP)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis